Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Immunology, Immunotherapy : CII|August 8, 2015
Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironmentJaime F Modiano, Beth A Lindborg, Ron T McElmurry, et al.
F1000Research|May 11, 2017
A double blinded, placebo-controlled pilot study to examine reduction of CD34 +/CD117 +/CD133 + lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphomaDaisuke Ito, Michael Childress, Nicola Mason, et al.
Plos One|June 20, 2014
Nfatc2 and Tob1 have non-overlapping function in T cell negative regulation and tumorigenesisSarah L May, Qing Zhou, Mitzi Lewellen, et al.
Veterinary Sciences|October 28, 2025
Extended Survival in a Dog with Primary Bone Hemangiosarcoma Following Treatment with Neoadjuvant Oncolytic Virotherapy and Standard of CareCourtney Labé, Andrea Chehadeh, Amber Winter, et al.
Molecular Cancer Research : MCR|October 2, 2019
Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human AngiosarcomaKate Megquier, Jason Turner-Maier, Ross Swofford, et al.
Toxins|September 27, 2024
Toxicity Profile of eBAT, a Bispecific Ligand-Targeted Toxin Directed to EGFR and uPAR, in Mice and a Clinical Dog ModelRose H Dicovitsky, Jill T Schappa, Ashley J Schulte, et al.
Cancer Research Communications|May 17, 2024
Hemangiosarcoma Cells Promote Conserved Host-derived Hematopoietic ExpansionJong Hyuk Kim, Ashley J Schulte, Aaron L Sarver, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 7, 2025
Remodeling the sarcoma microenvironment by simultaneous targeting of urokinase-type plasminogen activator receptors and epidermal growth factor receptors to promote antitumor activityAshley J Schulte, Mitzi Lewellen, Willa Durose, et al.
Pageof 1